AtriCure (ATRC) Return on Capital Employed (2011 - 2026)
AtriCure (ATRC) posted quarterly Return on Capital Employed of 2.23% for Q2 2026, up 864.0% year-over-year from 0.23% in Q2 2025, and up 532.56% quarter-over-quarter from 0.52% in Q1 2026.
AtriCure (ATRC) Return on Capital Employed (2011 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Return on Capital Employed for 16 consecutive years, with 2.23% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 864.0% year-over-year to 2.23%; the TTM figure through Jun 2026 stood at 2.23% (up 864.0% YoY), while the FY2025 annual figure was 1.72%, up 572.0% from the prior year.
- Return on Capital Employed climbed to 2.23% in Q2 2026 per ATRC's latest filing, from 0.52% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 11.01% in Q2 2022 and bottomed at 9.68% in Q3 2022.
- Historically, Return on Capital Employed has averaged 3.4% across 5 years, with a median of 5.44% in 2023.
- On a YoY basis, Return on Capital Employed climbed as much as 1930 bps in 2022 and fell as far as 1802 bps in 2022.
- AtriCure's Return on Capital Employed stood at 8.12% in 2022, then jumped by 38 bps to 5.01% in 2023, then sank by 48 bps to 7.43% in 2024, then soared by 77 bps to 1.68% in 2025, then soared by 233 bps to 2.23% in 2026.
- Business Quant data shows ATRC's Return on Capital Employed at 2.23% in Q2 2026, 0.52% in Q1 2026, and 1.68% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 2.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23% |
| Mar 31, 2026 | -0.52% |
| Dec 31, 2025 | -1.68% |
| Sep 30, 2025 | -4.86% |
| Jun 30, 2025 | -6.41% |
| Mar 31, 2025 | -6.50% |
| Dec 31, 2024 | -7.43% |
| Sep 30, 2024 | -6.42% |
| Jun 30, 2024 | -6.53% |
| Mar 31, 2024 | -5.88% |
| Dec 31, 2023 | -5.01% |
| Sep 30, 2023 | -4.30% |
| Jun 30, 2023 | -4.79% |
| Mar 31, 2023 | -6.57% |
| Dec 31, 2022 | -8.12% |
| Sep 30, 2022 | -9.68% |
| Jun 30, 2022 | 11.01% |
| Mar 31, 2022 | 10.30% |
| Dec 31, 2021 | 9.90% |
| Sep 30, 2021 | 8.32% |